FDA approved Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for the prevention of certain diseases caused by nine types of Human Papillomavirus.
NCI Director Harold Varmus addressed a joint meeting of the NCI Board of Scientific Advisors and the National Cancer Advisory Board Dec. 2, updating them on his proposed bypass budget for the institute, changes in Congressional leadership, and NCI and NIH grant policy.
NCI's Douglas Lowy and John Schiller were honored by President Barack Obama with a National Medal of Technology and Innovation, the nation's highest honor for technological achievement, for their work in developing a vaccine for human papilloma virus.
Daniel Hayes was elected president of the American Society of Clinical Oncology.
Early Friday morning, President Barack Obama signed a two-day funding resolution averting a government shutdown and giving the Senate time to debate a $1.1 trillion funding package passed by the House of Representatives late Thursday night.
Faculty members at MD Anderson Cancer Center are arguably the most intensely watched cohort in academic medicine. Their angst has been measured four times by three administrative entities over two years.
SEATTLE CHILDREN'S HOSPITAL and Research Foundation launched a $100 million, multi-year fundraising initiative to support patient access to clinical trials as well as immunotherapy research.
THE CROWDCARE FOUNDATION announced the first crowdfunding initiative for myeloma research at the 2014 conference of the American Society of Hematology.
PHARMACYCLICS Inc. was awarded the 2014 Society for Medicines Research Award for Drug Discovery for its discovery of Imbruvica (ibrutinib). The award was presented by the Society of Medicines Research at its biennial award lecture in London.
YALE UNIVERSITY and Organovo Holdings Inc. formed a collaboration to develop 3D bioprinted organ tissues for surgical transplantation research, made possible by a gift from the Methuselah Foundation.
